Intranasal Fentanyl Versus Placebo for Catheterization During a Voiding Cystourethrogram in Children
1 other identifier
interventional
64
1 country
1
Brief Summary
The purpose of this study is to determine whether intranasal fentanyl is better than placebo at decreasing pain in children 4-8 years of age during urinary catheterization for a VCUG study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3 pain
Started Nov 2006
Typical duration for phase_3 pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2006
CompletedFirst Submitted
Initial submission to the registry
November 28, 2006
CompletedFirst Posted
Study publicly available on registry
November 30, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2008
CompletedDecember 13, 2010
December 1, 2010
1.8 years
November 28, 2006
December 10, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in pain before and after catheterization for the VCUG.
Will be measured up until 30 mins after the VCUG procedure.
Secondary Outcomes (3)
Heart rate, respiratory rate and oxygen saturation just prior to and after the administration of fentanyl.
Every 5 minutes until 30 minutes after the VCUG procedure.
Nausea, vomiting, itching, nasal pain/irritation or any other side effects.
Will be measured up until 30 mins after the VCUG procedure.
Length of stay in diagnostic suite
Time frame determined by outcome
Study Arms (2)
1
EXPERIMENTAL2
PLACEBO COMPARATORInterventions
The dose of fentanyl that each child will receive will be 2 mcg/kg based on the child's weight. The medication will be administered 10 minutes prior to the procedure and will be dropped into the unoccluded nares over 1-2 seconds.
The dose of sterile water that each child will receive will be 2 mcg/kg based on the child's weight. It will be administered 10 minutes prior to the procedure and will be dropped into the unoccluded nares over 1-2 seconds.
Eligibility Criteria
You may qualify if:
- Age 4-8 years
- Scheduled VCUG at Sick Kids
- Understand the consent and assent form in English
You may not qualify if:
- Previous adverse events to fentanyl or any opioid
- History of a chronic respiratory or cardiac illness
- Children with developmental delay
- Children with bilateral nasal congestion.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Hospital for Sick Children
Toronto, Ontario, M5G 1X8, Canada
Related Publications (1)
Chung S, Lim R, Goldman RD. Intranasal fentanyl versus placebo for pain in children during catheterization for voiding cystourethrography. Pediatr Radiol. 2010 Jul;40(7):1236-40. doi: 10.1007/s00247-009-1521-1. Epub 2010 Feb 24.
PMID: 20180109BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Seen Chung, MD
The Hospital for Sick Children, Toronto Canada
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
November 28, 2006
First Posted
November 30, 2006
Study Start
November 1, 2006
Primary Completion
September 1, 2008
Study Completion
September 1, 2008
Last Updated
December 13, 2010
Record last verified: 2010-12